#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haematological malignancy Marfan's syndrome Alternating hemiplegia of childhood Polymyositis Mucopolysaccharidosis III Encephalopathy neonatal Hepatic angiosarcoma B precursor type acute leukaemia Renal cell carcinoma Endometrial cancer Hepatoblastoma Ovarian cancer stage IV Prolymphocytic leukaemia Cutaneous T-cell lymphoma Malignant oligodendroglioma More trials…

    Learn about Rare Diseases

    Rett syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Angiosarcoma – Treatment Marfan’s syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS Alagille syndrome – Trials in Disease Glycogen storage disease type II Krabbe’s disease – Treatment Activated PI3 kinase delta syndrome – Diagnostics Idiopathic inflammatory myopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Misoprostol Ucp4 Emibetuzumab Frexalimab PHENTOLAMINE MESILATE Rezpegaldesleukin Belzutifan Munc-T3 Tecaginlimab Avalglucosidase Alfa Metoclopramide Hydrochloride Duloxetine Lazertinib Zinc Acexamate Lenograstim Nnc0194-0499 Sumatriptan Succinate Levomepromazine Hydrochloride Arbaclofen Digoxin Immune Fab (Ovine) More therapies…

    Learn about Your Condition

    Cortical dysplasia Indolent systemic mastocytosis Dilated cardiomyopathy Sexual dysfunction Procedural headache Encephalitis Japanese B Adenocarcinoma Hepatic encephalopathy Lip and/or oral cavity cancer Acute myeloid leukaemia Chondrocalcinosis Liposarcoma Neuroendocrine tumour Overweight Desmoid tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz…

Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz

Seregelyesi Ut 3, Szekesfehervar, 8000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Postoperative wound infection
    Investigated Drugs:
    • Doxycycline Hyclate
    Germany Hungary Ireland Italy Poland Portugal +1

  • Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Abelacimab
    • Rivaroxaban
    Czechia Hungary Poland

  • Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Dexamethasone Isonicotinate
    Austria Belgium Denmark Finland France Germany +7

  • Study on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Benralizumab
    • Mometasone Furoate
    Belgium Bulgaria Hungary Italy Poland

  • Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Czechia Hungary Poland Spain

  • Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Pembrolizumab
    Austria Belgium France Germany Greece Hungary +6

  • Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Bulgaria Croatia Czechia France Germany Hungary +9

  • Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Czechia Denmark Germany Hungary Italy +5

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute kidney injury
    • Sepsis
    Investigated Drugs:
    • Tin816
    Austria Belgium Czechia France Germany Hungary +2
Previous Page
1 … 4 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!